Motus GI Hldgs (NASDAQ: MOTS)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -2.010 | (EXPECTED) 2022-08-11 | |||||
REV | 190.000K |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.110 | -0.090 | 0.0200 | ||||
REV | 80.000K | 20.000K | -60.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Motus GI Hldgs (NASDAQ: MOTS) through any online brokerage.
Other companies in Motus GI Hldgs’s space includes: ENDRA Life Sciences (NASDAQ:NDRA), Bluejay Diagnostics (NASDAQ:BJDX), Talis Biomedical (NASDAQ:TLIS), Medigus (NASDAQ:MDGS) and Viveve Medical (NASDAQ:VIVE).
The latest price target for Motus GI Hldgs (NASDAQ: MOTS) was reported by HC Wainwright & Co. on Tuesday, July 26, 2022. The analyst firm set a price target for 20.00 expecting MOTS to rise to within 12 months (a possible 403.78% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Motus GI Hldgs (NASDAQ: MOTS) is $3.97 last updated August 8, 2022, 8:00 PM UTC.
There are no upcoming dividends for Motus GI Hldgs.
Motus GI Hldgs’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for Motus GI Hldgs.
Motus GI Hldgs is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.